eTheRNA immunotherapies NV
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $81M
Investors
- 9
About eTheRNA immunotherapies NV
Founded in 2013, eTheRNA immunotherapies NV specializes in RNA technology and immunotherapy solutions.eTheRNA immunotherapies NV specializes in advanced RNA therapeutic solutions, including proprietary mRNA adjuvants like TriMix and TetraMix aimed at enhancing immune responses.
Who invested in eTheRNA immunotherapies NV
9 investors across 3 rounds
See all investors in eTheRNA immunotherapies NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about eTheRNA immunotherapies NV
Who invested in eTheRNA immunotherapies NV?
eTheRNA immunotherapies NV has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has eTheRNA immunotherapies NV raised?
eTheRNA immunotherapies NV has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did eTheRNA immunotherapies NV last raise money?
eTheRNA immunotherapies NV's most recent round on record is a Series B, in Aug 2022.
What does eTheRNA immunotherapies NV do?
Founded in 2013, eTheRNA immunotherapies NV specializes in RNA technology and immunotherapy solutions.
Where is eTheRNA immunotherapies NV headquartered?
eTheRNA immunotherapies NV is headquartered in Belgium.
Which VCs invest in companies like eTheRNA immunotherapies NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at eTheRNA immunotherapies NV's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like eTheRNA immunotherapies NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.